AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
22:59
Traian Băsescu, critic of the political class: "When we are left without electricity, when drones are falling around us, they are getting their hair done and going to Cotroceni"
22:48
Midfielder Damjan Djokovic unilaterally terminated the contract with CFR Cluj
22:40
Trade exchanges between Romania and the USA exceeded 7.8 billion dollars in 2025
22:33
Craiova University drew 1-1 in the first leg of the Europa League play-off against Ararat-Armenia.
22:19
USA: a 35-year-old woman has been accused of supporting ISIS and planning an attack on the Congress building in New York
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
